direkt zum Inhalt springen

direkt zum Hauptnavigationsmenü

Sie sind hier

TU Berlin

Inhalt des Dokuments

Publikationen 2012

  • Busse R (2012): Dealing with chronic disease - The role of structured programmes and guidelines (Editorial). Health Policy 107(2-3): 105-107 [1]
  • Busse R (2012): Gesundheitssystem- und Versorgungsforschung. In: HURRELMANN K, RAZUM O (Hrsg.): Handbuch Gesundheitswissenschaften. 5. vollst. überarb. Aufl. Weinheim und Basel: Beltz Juventa, S. 441-460 [2]
  • Busse R (2012): Health reform monitor—The impact of the financial crisis (Editorial). Health Policy 106(1): 1-2 [3]
  • Busse R (2012): Internationaler Vergleich: Was leisten Gesundheitssysteme? In: VÖLKER I, DORMANN F (Hrsg.) Soziale Ordnungspolitik im 21. Jahrhundert. Stuttgart-New York: Thieme, S. 138-144 [4]
  • Busse R (2012): Methods in health systems and policy research (Editorial). Health Policy 104(3): 205 [5]
  • Busse R (2012): Vielleicht die am wenigsten wahrgenommene, aber keinesfalls unwichtigste Rolle des Rainer Hess: the Federal Joint Committee’s Foreign Affairs. In: Begegnungen – Festschrift zur Verabschiedung von Dr. Rainer Hess ... [6]
  • Busse R, on behalf o.t. EuroDRG group (2012): Do Diagnosis-Related Groups explain variations in hospital costs an length of stay? - Analyses from the Eurodrg Project for 10 episodes of care across 10 european countries. Health Economics 21 (Suppl. 2): 1-5 [7]
  • Busse R, Geissler A, Mason A, Or Z, Scheller-Kreinsen D, Street A (Eds.) (2012): Diagnosis-Related Groups in Europe (EuroDRG): Do they explain variation in hospital costs and length of stay across patients and hospitals? Health Economics, Volume 21 [8]
  • Busse R, Valentine N, Lessof S, Prasad A, Van Ginneken E (2012): Being responsive to citizens’ expectations: the role of health services in responsiveness and satisfaction. In: MCKEE M, FIGUERAS J (eds.) Health Systems: ... [9]
  • Busse R, Van Ginneken E, Normand C (2012): Re-examining the cost pressures on health systems. In: MCKEE M, FIGUERAS J (eds.) Health Systems: Health, Wealth and Societal Well-Being. Maidenhead: OUP/ McGraw-Hill, p. 37-60 [10]
  • Aiken H, et. al. (2012): Patient safety, satisfaction, and quality of hospital care: cross sectional surveys of nurses and patients in 12 countries in Europe and the United States. BMJ 344:e1717 doi: 10.1136/bmj.e1717 (Published 20 March 2012) [11]
  • Augustin U, Henschke C (2012): Bringt das Telemonitoring bei chronisch herzinsuffizienten Patienten Verbesserungen in den Nutzen- und Kosteneffekten? – Ein systematischer Review. Das Gesundheitswesen 74(12):e114-e121. (DOI: 10.1055/s-0032-1309021) [12]
  • Bäumler M, Stargardt T, Schreyögg J, Busse R (2012): Cost Effectiveness of Drug-Eluting Stents in Acute Myocardial Infarction Patients in Germany: Results from Administrative Data Using a Propensity Score-Matching Approach. [13]
  • Brusamento S, Legido-Quigley H, Panteli D, Turk E, Knai C, Saliba V, Car J, McKee M, Busse R: Assessing the effectiveness of strategies to implement clinical guidelines for the management of chronic diseases at primary care level in EU Member States. [14]
  • De Bucourt M, Busse R, Güttler F, Reinhold T, Vollnberg B, Kentenich M, Hamm B, Teichgräber U (2012): Process Mapping of PTA and Stent Placement in a University Hospital Interventional Radiology Department. Insights into Imaging 3(4):329-36 [15]
  • Dimova A, Rohova M, Moutafova E, Atanasova E, Koeva S, Panteli D, van Ginneken E. Bulgaria: Health system review. Health Systems in Transition, 14(3):1–186. [16]
  • Geissler A, Scheller-Kreinsen D, Quentin W, Busse R (2012): DRG-Systeme in Europa - Anreize, Ziele und Unterschiede in zwölf Ländern. Bundesgesundheitsbl 55(5): 633–642 (DOI 10.1007/s00103-012-1473-8) [17]
  • Geissler A, Scheller-Kreinsen D, Quentin W, on behalf o.t. EuroDRG group: Do diagnosis-related groups appropriately explain variations in costs and length of stay of hip replacement? A comparative assessment of DRG systems across 10 european countries. [18]
  • Henschke C, Busse R (2012): Andere Länder, andere Zulassungen. Gesundheit und Gesellschaft - Spezial (Medizinprodukte "Mehr Sicherheit für Patienten") 15(11): 10 [19]
  • Henschke C, Busse R (2012): Hilfsmittelversorgung bei ALS und Duchenne – von der Beantragung bis zum Gebrauch. In: Schultz C, Schreyögg J (Hrsg.) Versorgungsforschung und Betroffenenalltag - ... Kiel/ Hamburg, S. 22-23 [20]
  • Henschke C (2012): Provision and financing of assistive technology devices in Germany: A bureaucratic odyssey? The case of amyotrophic lateral sclerosis and Duchenne muscular dystrophy. Health Policy 105(2-3): 176-84 (DOI:10.1016/j.healthpol.2012.01.013) [21]
  • Knai C, Brusamento S, Legido-Quigley H, Saliba V, Panteli D, Turk E, Car J, Mckee M, Busse R (2012): Systematic review of the methodological quality of clinical guideline development for the management of chronic disease in Europe. Health Policy [22]
  • Kreis J, Busse R (2012): From evidence assessments to coverage decisions? The case example of glinides in Germany. Health Policy 104(1): 27-31 [23]
  • Legido-Quigley H, Glinos IA, Baeten R, McKee M, Busse R (2012): Analysing arrangements for cross-border mobility of patients in the European Union: A proposal for a framework. Health Policy 108(1): 27-36 (DOI 10.1016/j.healthpol.2012.07.001) [24]
  • Legido-Quigley H, Panteli D, Brusamento S, Knai C, Saliba V, Turk E, Solé M, Augustin U, Car J, McKee M, Busse R (2012): Clinical guidelines in the European Union: Mapping the regulatory basis, development, quality control, implementation and ... [25]
  • Maier B, Behrens S, Busse R, Jonitz G, Schoeller R, Schuehlen H, Theres H (2012): Das Berliner Herzinfarkt-Register als Beispiel für ein klinisches Register. Public Health Forum 20(3): 18.e1-18.e3 [26]
  • Mershed M, Busse R, Van Ginneken E (2012): Health care financing in Syria: satisfaction with the current system and the role of national health insurance – a qualitative study of householders’ views. Int J Health Planning Management 27(2): 167-79 [27]
  • Ognyanova D, Busse R (2012): Health workforce mobility and policy responses in South-East Europe. In: Bartlett W, Bozikov J, Rechel B (eds.) Health Reforms in South-East Europe. Houndsmills: Palgrave Macmillan, p. 76-101 [28]
  • Ognyanova D, Maier CB, Wismar M, Girasek E, Busse R (2012): Mobility of health professionals pre and post 2004 and 2007 EU enlargements: Evidence from the EU project PROMeTHEUS. Health Policy 108(2-3): 122-132 (DOI 10.1016/j.healthpol.2012.10.006) [29]
  • O’Reilly J, Busse R, Häkkinen U, Or Z, Street A, Wiley M (2012): Paying for hospital care: the experience with implementing activity-based funding in five European countries. Health Economics, Policy and Law 7(1): 73-101 (DOI: 10.1017/S1744133111000314) [30]
  • Ozegowski S, Sundmacher L (2012): Ensuring access to health care—Germany reforms supply structures to tackle inequalities. Health Policy 106(2): 105-109 [31]
  • Quentin W, Scheller-Kreinsen D, Geissler A, Busse R (2012): Appendectomy and diagnosis-related groups (DRGs): patient classification and hospital reimbursement in 11 European countries. Langenbecks Arch Surg 397(2): 317-326 (DOI 10.1007/s00423-011-0877-5) [32]
  • Quentin W, Terris-Prestholt F, Changalucha J, Soteli S, Edmunds WJ, Hutubessy R, Ross DA, Kapiga S, Hayes R, Watson-Jones D (2012): Costs of delivering human papillomavirus vaccination to schoolgirls in Mwanza Region, Tanzania. BMC Medicine 10:137 [33]
  • Röttger J, Scheller-Kreinsen D, Busse R (2012): Patient-level hospital costs and length of stay after conventional versus minimally invasive total hip replacement: A propensity-matched analysis. Value in Health 15(8):999-1004(DOI 10.1016/j.jval.12.06.008) [34]
  • Scheller-Kreinsen D, on behalf of the EuroDRG group (2012): How well do diagnosis-related group systems group breast cancer surgery patients? - Evidence from 10 european countries. Health Economics 21 (Suppl. 2): 41-54 [35]
  • Scheller-Kreinsen D, Quentin W, Reichle C, Röttger J, Geissler A, Busse R (2012): Technologische Innovationen und DRGs: Ein Vergleich der Vergütungsinstrumente in 11 europäischen Ländern. In: KLAUBER J, GERAEDTS M, FRIEDRICH J, WASEM J (Hrsg.) [36]
  • Schultz C, Schreyögg J, Stargardt T, Busse R (2012): Focus on designing health care structures and services for rare diseases (Editorial). Health Policy 105(2-3): 107-109 [37]
  • Schwartz FW, Busse R (2012): Denken in Zusammenhängen – Gesundheitssystemforschung. In: SCHWARTZ FW, WALTER U, SIEGRIST J, KOLIP P, LEIDL R, DIERKS M-L, BUSSE R, SCHNEIDER N (Hrsg.) Public Health: Gesundheit und Gesundheitswesen. 3. Auflage. [38]
  • Smith PC, Anell A, Busse R, Crivelli L, Healy J, Lindahl AK, Westert G, Kene T (2012): Leadership and Governance in Seven Developed Health Systems. Health Policy 106(1): 37-49 (DOI:10.1016/j.healthpol.2011.12.009) [39]
  • Squires A, Bruyneel L, Aiken LH, van den Heede K, Sermeus W, Brzostek T, Busse R, Ensio A, Schubert M, Zikos D (2012): Cross-Cultural Evaluation of the Relevance of the HCAHPS Survey in Five European Countries. Int J Quality Health Care 24(5): 470-475 [40]
  • Stargardt T, Edel M-A, Ebert A, Busse R, Juckel G, Gericke CA (2012): Effectiveness and cost of atypical versus typical antipsychotic treatment in a nationwide cohort of schizophrenic patients in Germany. Journal of Clinical Psychopharmacology 32(5) [41]
  • Sundmacher L (2012): The Effect of Health Shocks on Smoking and Obesity. European Journal of Health Economics 13(4):451-460 (DOI:10.1007/s10198-011-0316) [42]
  • Sundmacher L, Bäumler M, Busse R (2012): Der Einfluss von Ärztedichte auf ambulant-sensitive Krankenhausfälle. In: KLAUBER J, GERAEDTS M, FRIEDRICH J, WASEM J (Hrsg.) Krankenhaus-Report 2012. Schwerpunkt: Regionalität. Stuttgart: Schattauer, S. 183-202 [43]
  • Sundmacher L, Hofmann K, Gaskins M, Busse R (2012): Spatial distribution of avoidable cancer mortality in Germany. J Public Health 20(3): 279-288 (DOI 10.1007/s10389-011-0441-3) [44]
  • Tiemann O, Schreyögg J, Busse R (2012): Hospital ownership and efficiency – A review of studies with particular focus on Germany. Health Policy 104(2): 163-171 (DOI:10.1016/j.healthpol.2011.11.010) [45]
  • van Ginneken E, Groenewegen PP, McKee M (2012): Personal healthcare budgets: what can England learn from the Netherlands? BMJ 344:e1383 (DOI 10.1136/bmj.e1383) [46]
  • Van Ginneken E, Habicht J, Murauskiene L, Behmane D, Mladovsky P (2012): The Baltic states: building on 20 years of health reforms. BMJ 345:e7348 [47]
  • Van Ginneken E, Sturma J (2012): Responsibility and Accountability in the Czech Health System. In: Rosen B, Israeli A, Shortell S (eds). Accountability and Responsibility in Health Care - An Emerging Global Issue. World Scientific, p. 127-132 [48]
  • van Ginneken E, Swartz K (2012): Implementing Insurance Exchanges — Lessons from Europe. New England Journal of Medicine 367(8):691-693 (DOI 10.1056/NEJMp1205832) [49]
  • Vuong DA, Rades D, Le Ann, Busse R (2012): Cost effectiveness of stereotactic radio-surgery versus surgical resection in the treatment of brain metastasis in Vietnam with perspectives of patient and family. World Neurosurgery 77(2): 321-328 [50]
  • Zander B, Busse R (2012): Das Arbeitsumfeld als (Qualitäts-) Indikator für Patienten- und Pflegeergebnisse. In: BECHTEL P, SMERDKA-ARHELGER I. (Hrsg.): Pflege im Wandel gestalten – Eine Führungsaufgabe. Berlin und Heidelberg: Springer, S. 109-121 [51]
  • Zander B, Dobler L, Busse R (2012): Pflegepersonaleinsatz: Studie zeigt alarmierende Ergebnisse. Die Schwester Der Pfleger 51(6): 592-596 [52]
  • Zentner A, Rüther A, Perleth M (2012): Nutzenbewertung von Arzneimitteln: Wie viel Europa darf es sein? Dtsch Arztebl 109(8): A-358 / B-314 / C-310 [53]

Nach oben

------ Links: ------

Zusatzinformationen / Extras

Direktzugang

Schnellnavigation zur Seite über Nummerneingabe

Hilfsfunktionen

Copyright TU Berlin 2008